Stephen Hart

Stephen Hart has a diverse work experience in the pharmaceutical and healthcare industry. Stephen is currently working as the Senior Director Portfolio Strategy at Sobi - Swedish Orphan Biovitrum AB. Prior to this, they held various roles at The Janssen Pharmaceutical Companies of Johnson & Johnson, including Director Global New Business Development and Global Marketing Leader. Stephen was also the General Manager ASEAN at Actelion and the Medical Director ANZ. Stephen began their career at Sanofi, where they worked as the Director of Medical Communications and Senior Medical Manager. Stephen's early experience includes working as a Senior Scientific Advisor at Schering AG.

Stephen Hart has a Bachelor of Pharmacy (BPharm) degree from the University of Otago, which they obtained from 1995 to 1998. Stephen then pursued further education at the Macquarie Graduate School of Management (MGSM), where they obtained a Master of Management degree in General Management and Financial Management from 2009 to 2011. Additionally, they obtained a Master of Business Administration (MBA) degree in Business Administration and Management, General from MGSM from 2014 to 2016. Stephen Hart also has additional certifications, including High Performance Leadership from IMD in 2016, and certifications for their MBA and Master of Management degrees.